Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each with its distinct pathophysiology.
Gastritis is an inflammation of the stomach lining that causes the gastric mucosa to become hyperemic and edematous, leading to superficial erosion.
It can arise from various causes, each with its unique pathophysiology.
For instance, non-steroidal anti-inflammatory drugs or NSAIDs inhibit cyclooxygenase-1, an enzyme vital in prostaglandin production.
Prostaglandins are essential for maintaining mucosal integrity, mucus and bicarbonate secretion, and mucosal blood flow.
NSAID-induced reduction in prostaglandin levels leads to decreased mucus and bicarbonate secretion, making the stomach lining more vulnerable to the corrosive impacts of gastric juice.
Another prevalent cause is H. pylori, a bacterium implicated in chronic gastritis, which adapts to the stomach's acidic environment by producing urease.
This enzyme converts urea to ammonia, creating a less acidic environment that favors bacterial survival.
Once established, H. pylori triggers an immune response and releases toxins, resulting in mucosal inflammation and damage.